{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:21Z","timestamp":1770750261346,"version":"3.50.0"},"reference-count":19,"publisher":"BMJ","issue":"e1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,4,21]]},"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1136\/ejhpharm-2019-002133","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T21:58:55Z","timestamp":1589407135000},"page":"e47-e50","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study"],"prefix":"10.1136","volume":"28","author":[{"given":"Marisol","family":"Samart\u00edn-Ucha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Maria","family":"Pego-Reigosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"\u00c1lvarez-Payero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Martin-Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Pineiro-Corrales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Benito","family":"Melero-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Maceiras-Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Martinez-Reglero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Mrtinez-Lopez de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"2024052711105094000_28.e1.e47.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11439"},{"key":"2024052711105094000_28.e1.e47.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"key":"2024052711105094000_28.e1.e47.3","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200209000-00009"},{"key":"2024052711105094000_28.e1.e47.4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/CEOR.S66338","article-title":"Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study","volume":"6","author":"Degli Esposti","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"2024052711105094000_28.e1.e47.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"key":"2024052711105094000_28.e1.e47.6","first-page":"96","article-title":"Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"29","author":"R\u00e9my","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2024052711105094000_28.e1.e47.7","doi-asserted-by":"publisher","DOI":"10.1186\/ar1941"},{"key":"2024052711105094000_28.e1.e47.8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40744-017-0078-y","article-title":"Discontinuation of biologic therapy in rheumatoid arthritis: analysis from the CORRONA RA Registry","volume":"4","author":"Strand","year":"2017","journal-title":"Rheumatol Ther"},{"key":"2024052711105094000_28.e1.e47.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200302"},{"key":"2024052711105094000_28.e1.e47.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker281"},{"key":"2024052711105094000_28.e1.e47.11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semarthrit.2017.03.010","article-title":"Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions","volume":"47","author":"Calip","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2024052711105094000_28.e1.e47.12","first-page":"254","article-title":"High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients","volume":"36","author":"Thomas","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2024052711105094000_28.e1.e47.13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10067-017-3712-8","article-title":"Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences","volume":"36","author":"Favalli","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2024052711105094000_28.e1.e47.14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1756-185X.13243","article-title":"A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population","volume":"21","author":"Jones","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2024052711105094000_28.e1.e47.15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2018.1447264","article-title":"Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data","volume":"29","author":"Takabayashi","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2024052711105094000_28.e1.e47.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2024052711105094000_28.e1.e47.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108217"},{"key":"2024052711105094000_28.e1.e47.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"key":"2024052711105094000_28.e1.e47.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2019-002133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T18:11:02Z","timestamp":1716833462000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2019-002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":19,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2021,11,29]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/ejhpharm-2019-002133"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2019-002133","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]}}}